December 15th, 2015

Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Who Likes Gilead, Celgene and Biogen? Nomura Does, That’s Who

[at Barrons.com] – Take that Goldman Sachs. Nomura’s started covering biotech companies–and boy are its analysts feeling bullish. Of the 11 stocks it covers, eight get a Buy rating, including large-caps Gilead (GILD), . . . → Read More: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Who Likes Gilead, Celgene and Biogen? Nomura Does, That’s Who
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.